Cargando...
A phase I and pharmacokinetic study of the combination of capecitabine and docetaxel in patients with advanced solid tumours
Capecitabine and docetaxel are both active against a variety of solid tumours, while their toxicity profiles only partly overlap. This phase I study was performed to determine the maximum tolerated dose (MTD) and side-effects of the combination, and to establish whether there is any pharmacokinetic...
Guardado en:
| Autores principales: | , , , , , , , , |
|---|---|
| Formato: | Artigo |
| Lenguaje: | Inglês |
| Publicado: |
Nature Publishing Group
2000
|
| Materias: | |
| Acceso en línea: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2374547/ https://ncbi.nlm.nih.gov/pubmed/10883663 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1054/bjoc.2000.1160 |
| Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|